α-Melanocyte-stimulating hormone : From bench to bedside;α-Melanozyten-stimulierendes Hormon : Von der Forschung in die Klinik

Hautarzt

Volumn 61, Issue 6, 2010, Pages 497-504

  Bohm M ^a   Luger, T A ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Melanocyte stimulating hormone; Afamelanotide; Melanocortin receptors; Pigmentation; Proopiomelanocortin

Indexed keywords

AFAMELANOTIDE; ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; BETA ENDORPHIN; BETA INTERMEDIN; BETA LIPOTROPIN; CORTICOTROPIN; GAMMA INTERMEDIN; GAMMA LIPOTROPIN; LYSYLASPARTYLPROLYLTHREONINE; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; NDP ALPHA MELANOCYTE STIMULATING HORMONE; PROOPIOMELANOCORTIN; TRIPEPTIDE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; MELANIN;

AMINO ACID SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CELL PROTECTION; CLINICAL TRIAL; DERMATOLOGY; DRUG EFFECT; DRUG EFFICACY; EPIDERMIS; ERYTHROPOIETIC PROTOPORPHYRIA; EXON; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE STRUCTURE; HUMAN; LIPOGENESIS; MELANOCYTE; MOLECULAR MECHANICS; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; SKIN PIGMENTATION; SKIN PROTECTION; ULTRAVIOLET RADIATION; ANALOGS AND DERIVATIVES; MEDICAL RESEARCH; METABOLISM; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHOTOSENSITIVITY DISORDERS; PHYSIOLOGY; PROTOPORPHYRIA, ERYTHROPOIETIC; SKIN; SUBCUTANEOUS DRUG ADMINISTRATION; SUNBATHING;

ALPHA-MSH; ANTI-INFLAMMATORY AGENTS; BIOMEDICAL RESEARCH; CLINICAL TRIALS, PHASE II AS TOPIC; HUMANS; INJECTIONS, SUBCUTANEOUS; MELANINS; PHOTOSENSITIVITY DISORDERS; PRO-OPIOMELANOCORTIN; PROTOPORPHYRIA, ERYTHROPOIETIC; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN; SKIN PIGMENTATION; SUNBATHING;

EID: 77954425178     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-009-1891-1     Document Type: Review

References (37)

1. Abdel-Malek ZA, Ruwe A, Kavanagh-Starner R et al (2009) Alpha-MSH tripeptide analogs activate the melanocortin 1 receptor and reduce UV-induced DNA damage in human melanocytes. Pigment Cell Melanoma Res 22:635-644
2. Barnetson RS, Ooi TK, Zhuang L et al (2006) [Nle4-D-Phe7]-alpha- melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers. J Invest Dermatol 126:1869-1878
3. Böhm M, Schiller M, Stadler R et al (2001) Diffuse melanosis arising from metastatic melanoma: pa-thogenetic function of elevated melanocyte pep-tide growth factors. J Am Acad Dermatol 44:747754
4. Böhm M, Luger TA, Tobin DJ, García-Borrón JC (2006) Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol 126:1966-1975
5. Böhm M, Raghunath M, Sunderkötter C et al (2004) Collagen metabolism is a novel target of the neuropeptide a-melanocyte-stimulating hormone. J Biol Chem 279:6959-6966
6. Böhm M, Wolff I, Scholzen TE et al (2005) Alpha-melanocyte- stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280:5795-5802
7. Brzoska T, Luger TA, Maaser C et al (2008) a-mela-nocyte-stimulating hormone and related tripep-tides. Biochemistry, anti-inflammatory and protective effects in vitro and in vivo and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29:581-602
8. Clément K, Dubern B, Mencarelli M et al (2008) Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene. J Clin Endocrinol Metab 93:4955-4962
9. Cui R, Widlund HR, Feige E et al (2007) Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128:853-864
10. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S (1988) Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698-700
11. Hadley ME, Dorr RT (2006) Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides 27:921-930
12. Harms J, Lautenschlager S, Minder CE, Minder EI (2009) An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria. N Engl J Med 360:306-307
13. Harms JH, Lautenschlager S, Minder CE, Minder EI (2009) Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone. Photo-chem Photobiol 85:1434-1439
14. Ito T, Ito N, Bettermann A et al (2004) Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164:623-634
15. Kadekaro AL, Kavanagh R, Kanto H et al (2005) Al-pha-Melanocortin and endothelin-1 activate an-tiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 65:4292-4299
16. Kokot A, Metze D, Mouchet N et al (2009) a-MSH counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. Endocrinology 150:3197-3206
17. Kokot A, Sindrilaru A, Schiller M et al (2009) a-Me-lanocyte-stimulating hormone suppresses bleo-mycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma. Arthritis Rheum 60:592-603
18. Krude H, Biebermann, Luck W et al (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157
19. Loser K, Brzoska T, Oji V et al (2010) The neuropep-tide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans. PLoS One 5: e8958
20. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-1251
21. Park HY, Kosmadaki M, Yaar M, Gilchrest BA (2009) Cellular mechanisms regulating human melano-genesis. Cell Mol Life Sci 66:1493-1506
22. Perez Oliva AB, Fernendez LP, Detorre C et al (2009) Identification and functional analysis of novel variants of the human melanocortin 1 receptor found in melanoma patients. Hum Mutat 30:811-822
23. Rousseau K, Kauser S, Pritchard LE et al (2007) Proopiomelanocortin (POMC), the ACTH/mela-nocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 21:1844-1856
24. Sawyer TK, Sanfilippo PJ, Hruby VJ et al (1980) 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-me-lanotropin with ultralong biological activity. Proc Natl Acad Sci U S A 77:5754-5758
25. Schiller M, Raghunath M, Metze D et al (2001) Human dermal fibroblasts in vitro express the PC1 and PC2 and produce the POMC-derived peptides. J Invest Dermatol 117:227-235
26. Schiller M, Brzoska T, Böhm M et al (2004) Solar-simulated UVR-induced upregulation of the mela-nocortin-1 receptor, pro-opiomelanocortin and a-melanocyte-stimulating hormone in human epidermis in vivo. J Invest Dermatol 122:468-476
27. Scholzen T, Kalden DH, Brzoska T et al (2000) Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and in-terleukin-1. J Invest Dermatol 115:1021-1028
28. Scholzen TE, Sunderkotter C, Kalden DH et al (2003) Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144:360-370
29. Seidah NG, Benjannet S, Hamelin J et al (1999) The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Ann N Y Acad Sci 885:57-74
30. Song X, Mosby N, Yang J et al (2009) alpha-MSH activates immediate defense responses to UV-in-duced oxidative stress in human melanocytes. Pigment Cell Melanoma Res 22:809-818
31. Slominski A, Wortsman J, Luger T et al (2000) Corti-cotropin releasing hormone and proopiomelano-cortin involvement in the cutaneous response to stress. Physiol Rev 80:979-1020
32. Spencer JD, Gibbons NC, Rokos H et al (2007) Oxi-dative stress via hydrogen peroxide affects proo-piomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 127:411-420
33. Spencer JD, Schallreuter KU (2009) Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-sti-mulating hormone/melanocortin-4 receptor signaling. Endocrinology 150:1250-1258
34. Sturm RA, Duffy DL, Box NF et al (2003) Genetic association and cellular function of MC1R variant al-leles in human pigmentation. Ann N Y Acad Sci 994:348-358
35. Zhang L, Li WH, Anthonavage M, Eisinger M (2006) Melanocortin-5 receptor: a marker of human sebo-cyte differentiation. Peptides 27:413-420
36. Mastrofrancesco A, Kokot A, Eberle A et al (in Revision) KdPT, a tripeptide derivative of a-MSH, is a suppressor of proinflammatory cytokine expression and signaling in human sebocytes. J Immunol
37. Bettenworth D, Böhm M, Mennigen R et al. (eingereicht) The tripeptide KdPT protects from intestinal inflammation by maintaining intestinal barrier function. J Am Pathol 478-486